Other content in this Stream
7 Ways to Prepare for the EU Portal
User Experience (UX) to Help Participants Find Trials on the Web
A dedicated clinical trials website helps sponsors boost patient engagement by connecting with candidates, matching them to trials, and informing them about its disclosure and transparency policies.
Industry Leaders Connect at 2018 Strategic Partner Meeting
Deborah Collyar and Jennifer Van Ekelenburg spoke at TrialScope's 2018 Strategic Partner Summit, where the Clārus Awards were presented for commitment to clinical trial disclosure and transparency.
Why EU clinical trials are missing results
Thomas Wicks, Chief Strategy Officer at TrialScope, analyzes why about 50 percent of EU clinical trials are missing results.
Advisory Services: Disclosure Compliance Review
TrialScope Advisory Services
How to Boost Disclosure Efficiencies with Outsourcing
The Plain Truth About Outsourcing Plain-Language Summaries
"Makes a difficult, cumbersome submission process streamlined"
Meeting the EU CTR Compliance Challenge Head-On
Looking at public data on EU CTR as of July 16, a TrialScope analysis found a total of the over 16,000 clinical trials that ended more than 12 months earlier, only around 10,000 had results posted.
Clinical Trial Websites: Challenging the Status Quo
"There is simply no way I could manage without TrialScope"
A Recap of the FDA Civil Penalties Draft Guidance (Sep. ‘18)
5 Benefits to Developing a Global Transparency Policy
"Extremely satisfied and happy"
Introducing: Transparency Management with TrialScope
TrialScope Unveils Clinical Trial Transparency and Health Literacy Service
TrialScope has launched a transparency solution enabling clinical trial sponsors to engage with patients, healthcare professionals, researchers and the public via a dedicated informational website.
2 Steps for Correcting Non-compliance with EU Disclosure Regulations
On the EU CTR registry, many clinical trial results unavailable, and it appears many studies were registered but never updated. Here's a two-step process on how to correct this non-compliance.
"Head and shoulders above the rest"